Business
Haleon Full Year Results 2022
Haleon Full Year Results 2022.
About this update from Haleon Plc
[{"type":"text","content":"\n \n \n 2 March 2023\n \n \n \n \n \n \n \n 2022 Full year results \n \n \n Twelve months ended 31 December 2022 (unaudited)\n \n \n \n \n \n \n \n \n \n \n Strong growth with a healthy balance of price and positive volume/mix\n \n \n \n \n \n \n \n ●\n \n \n \n \n FY Revenue +13.8% to £10,858m, organic growth +9.0% with 4.3% price and 4.7% volume/mix\n \n \n \n \n \n \n ●\n \n \n \n \n Positive Power Brand performance across the portfolio, +10.1% organic growth\n \n \n \n \n \n \n ●\n \n \n \n \n 2/3 of our business gained or maintained market share1 in the 12 months ended 31 December 2022\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Pricing and efficiencies offsetting inflationary pressures\n \n \n \n \n \n \n \n ●\n \n \n \n \n FY Reported operating profit increased 11.4% to £1,825m\n \n \n \n \n \n \n ●\n \n \n \n \n FY Adjusted operating profit increased 13.8% to £2,472m, up 5.9% constant currency\n \n \n \n \n \n \n ●\n \n \n \n \n FY Adjusted operating profit margin 22.8%, flat year on year\n \n \n \n \n \n \n \n \n \n \n \n \n Continued high cash generation\n \n \n \n \n \n \n \n ●\n \n \n \n \n FY net cash flow from operating activities was £2,063m, which included £435m related to the net cash outflow from separation, restructuring and disposals; FY 2022 Free cash flow of £1,579m\n \n \n \n \n \n \n ●\n \n \n \n \n Net debt at 31 December 2022 was £9,868m, with 3.6x net debt/adjusted EBITDA\n \n \n \n \n \n \n ●\n \n \n \n \n Inaugural final dividend proposed of 2.4p per share in respect of trading since demerger on 18 July 2022\n \n \n \n \n \n \n \n \n \n \n \n \n Positive outlook for 20232, settlement on majority of PPI cases\n \n \n \n \n \n \n \n ●\n \n \n \n \n FY2023 organic revenue growth expected to be 4-6%\n \n \n \n \n \n \n ●\n \n \n \n \n FY2023 adjusted operating profit margin broadly flat after adverse transactional FX of c. 40bps\n \n \n \n \n \n \n ●\n \n \n \n \n Settlement reached to resolve the vast majority of PPI cases (Nexium24HR and Prevacid24HR)\n \n \n \n \n \n \n ●\n \n \n \n \n Positioned well to deliver on medium term guidance\n \n \n \n \n \n \n \n \n \n Brian McNamara, Chief Executive Officer, Haleon said:\n \n \n \n \n \n \n \"2022 was an extraordinary year for Haleon, having successfully demerged from GSK to become the first listed company 100% focused on co...